There's No Industrial Biocatalyst Like Hydrolase: Development of Scalable Enantioselective Processes Using Hydrolytic Enzymes1
详细信息    查看全文
文摘
Chiral, racemic esters, ethyl (±)-tetrahydrofuran-2-carboxylate4c, methyl (±)--phenylpropionate 9b, methyl (±)-5,5-dimethyl-1,3-thiazolidine-4-carboxylate 12a, 2-methoxyethyl (±)-1-(4-tert-butylphenyl)-2-oxopyrrolidine-4-carboxylate 15a, (±)-1-benzyloxy-3-chloropropan-2-yl hydrogen succinate 18c, and (±)-3-butyryloxyquinuclidinium butyrate [(±)-20b·n-PrCO2H], areresolved kinetically by enantioselective hydrolysis catalyzed byan Aspergillus melleus protease [E = 60; 93.9% ee and 35%yield for (R)-tetrahydrofuran-2-carboxylic acid 4a], a Klebsiellaoxytoca hydrolase [E > 200; 99.5% ee and 36% yield for (S)--phenylpropionic acid 9a], a K. oxytoca hydrolase [E = 145;97.7% ee and 34% yield for (R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid 12b], a Bacillus brevis protease [E = 77; 99%ee and 45% yield for (S)-15a], a Serratia marcescence esterase[E = 49; 99% ee and 43% yield for (S)-18c], and an A. melleusprotease [E = 96; 96% ee and 42% yield for (R)-20b], respectively. Each enzymatic process is discussed with focus on thefollowing tactical issues: (1) identification of a hydrolase withhigh enantioselectivity, (2) substrate concentrations not less than1 M that allow for industrially viable volume efficiency (space-time yield), (3) product separation by partition between organicand aqueous phases, and (4) alleviation of a hydrolysateinhibiting the enzymatic activity.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700